U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07314853) titled 'Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial' on Dec. 18, 2025.
Brief Summary: The goal of this clinical trial is to learn if using artificial intelligence to guide intravenous fluid therapy during major cancer surgery can help keep blood pressure more stable compared with usual care in adult patients undergoing major cancer surgery. The main questions it aims to answer are:
Does artificial intelligence-guided fluid therapy reduce hypotensive events during surgery?
Does this approach improve recovery and reduce complications after major cancer surgery?
Researchers ...